Join Us at AUA 2026

Written By Angel Wang

We’re heading to Washington D.C. for the 2026 American Urological Association (AUA) Annual Meeting.

From May 15-17 in Washington D.C., our team will be on-site to showcase the latest prognostic tool in prostate cancer risk stratification – OncoAssure Prostate.

Visit us at Booth #4108 to:

  • Review the Data: Dive into the clinical evidence supporting OncoAssure Prostate including the latest data we will present at the AUA conference:

o   “Clinical utility and prognostic value of the OncoAssure Prostate test for aggressive prostate cancer among clinically low risk patients.”

  • Consult with the Team: Discuss how to integrate OncoAssure Prostate into your current workflow

  • Explore Collaboration Opportunities: Discuss how you can collaborate with OncoAssure

Angel Wang
Next

OncoAssure Announces Collaboration with Leading US Medical Centre for Prostate Cancer Test Validation Study